Résultats de recherche

Le complexe Elongator intervient dans l'ajout de modifications dérivées du 5'-carboxylméthyluridine (cm5U) sur les ARN de transfert (ARNt), influençant ainsi la traduction de certains ARN messagers (ARNm) et contribuant à maintenir l'intégrité du protéome. Ce complexe est impliqué dans divers processus biologiques et revêt une importance particulière en cancérologie. L'identification d'inhibiteurs chimiques d'Elongator présente un intérêt significatif tant dans la recherche fondamentale que dans la recherche pharmaceutique.Grâce à un criblage en levure, ce travail révèle un nouveau rôle potentiel pour Elongator et identifie un inhibiteur chimique du complexe. Ce composé se présente comme un candidat intéressant en tant qu'inhibiteur pharmacologique, ouvrant ainsi de nouvelles perspectives pour la recherche de thérapies anticancéreuses.

NARILIS is pleased to invite its members from UNamur and CHU UCL Namur to come together on December 17, 2024, for an exciting afternoon of scientific exchange. The program will run over an afternoon, and will feature many scientific talks and a "speed dating" poster session. The day will end with a festive walking dinner to celebrate all the successes of the year!This event is a fantastic opportunity to showcase your research. We encourage all researchers and clinician-researchers to actively participate and submit their communication proposals. Here’s how you can get involved:20-min talks in duo, trio or quatuor“My thesis in 5 minutes”Posters More info on the NARILIS website

EMBO Courses and Workshops are selected for their excellent scientific quality and timelines, provision of good networking activities for all participants and speaker gender diversity (at least 40% of speakers must be from the underrepresented gender). Organisers are encouraged to implement measures to make the meeting environmentally more sustainable.Upon registration - More info and registration on the EMBO website.

Thematic sessionsThe day will be organized in two thematic sessions:Cancer metabolismNew advances in cancer therapyInvited speakersProf. Rebecca FITZGERALD, Early Cancer Institute, University of Cambridge, UKDr. Sébastien DUTERTRE, IBMM, University of Montpellier, FranceProf. Sarah-Maria FENDT, Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven, BelgiumDr. Arnaud BLOMME, Laboratory of Metabolic Regulation, GIGA Institute, University of Liège, Belgium Call for communicationsYoung researchers are invited to submit abstracts for oral communications and posters. All topics related to the field of cancer research are welcome. The deadline for abstract submission is April 1, 2025. Organizing committeeProf. Jean-Pierre Gillet - UNamur, NARILIS, Laboratory of Molecular Cancer BiologyProf. Marc Hennequart - UNamur, NARILIS, Laboratory of Cancer metabolismProf. Marielle Boonen - UNamur, NARILIS, Laboratory of Intracellular Trafficking BiologyProf. Benjamin Beck - ULB, IRIBHMProf. Lionel D'Hondt - CHU UCL Namur, Department of Oncology More info

La deadline d'inscription et de soumission pour les abstracts : 20 août 2025.  Plus d'infos sur le site internet de l'Institut NARILIS

2025 theme: Stress and emotions in animals The purpose of the symposium aligns with the missions of BCLAS to promote the replacement, reduction and refinement of laboratory animal use by driving reflection, sharing information, providing education and support to the scientific community, authorities and public, in order to lead to an ethical, responsible and qualitative research enabling further improvement in human & animal health.

Public cibleMédecins généralistes (en activité ou en formation)PharmaciensÉtudiants en médecine et en pharmacieObjectifsPartager et discuter d’articles scientifiques pertinents pour la pratique de première ligne dans un climat convivial et bienveillantRenforcer les compétences en lecture critique et en médecine fondée sur les preuvesCréer un lien durable entre le terrain et le monde académiqueFédérer une communauté médico-pharmaceutique active et engagéePourquoi participer ?Parce que la science évolue vite, et que nous gagnons tous à prendre le temps de lire, comprendre, et questionner la littérature ensemble. Parce que le soin de qualité commence par une réflexion partagée. Et parce que c’est l’occasion idéale de renforcer les ponts entre disciplines.Lieu et fréquence des rencontresUNamur - Quai22 - 2 fois par anPremière rencontre : 5/06/2025 (gratuit sur inscription)Accréditation INAMI demandé. Je m'inscris

Charting the DNA methylome landscape in cancer, chronic disease and phenotype Abstract: Our team has developed some of the first pipelines for genome-scale DNA methylation analysis. Our work has revealed aberrant methylation and expression patterns in several cancer types and revealed new mechanism of epigenetic regulation in cancer cells. We are now applying cutting-edge whole genome scale DNA methylation analysis in tissues as well as well as in cell free DNA (epigenetic liquid biopsy) and epigenetic editing platforms to investigate clinically relevant biomedical questions in cancer (for example, methylation map of colorectal, prostate, lung cancer and pancreatic cancer patients). Our work in epigenetic editing has implication in revealing causal function and new epigenetic regulation. In this talk, I will present the key findings from some of our works over the years and also elaborate on some recent and future directions in understanding the role of DNA methylation events in cancer metastasis, early detection, and treatment monitoring in solid cancers and also in chronic diseases and phenotype. More information on the ILEE website

Abstract Radiotherapy is a cornerstone of cancer treatment and is currently administered to approximately half of all cancer patients. However, the cytotoxic effects of ionizing radiation on normal tissues represent a major limitation, as they restrict the dose that can be safely delivered to patients and, consequently, reduce the likelihood of effective tumor control. In this context, delivering radiation at ultra-high dose rates (UHDR, > 40 Gy/s) is gaining increasing attention due to its potential to spare healthy tissues surrounding the tumor and to prevent radiation-induced side effects, as compared to conventional dose rates (CONV, on the order of Gy/min).The mechanism underlying this protective effect—termed the FLASH effect—remains elusive, driving intensive research to elucidate the biological processes triggered by this type of irradiation.In vitro models offer a valuable tool to support this research, allowing for the efficient screening of various beam parameters and biological responses in a time- and cost-effective manner. In this study, multicellular tumor spheroids and normal cells were exposed to proton irradiation at UHDR to evaluate its effectiveness in controlling tumor growth and its cytotoxic impact on healthy tissues, respectively.We report that UHDR and CONV irradiation induced a comparable growth delay in 3D tumor spheroids, suggesting similar efficacy in tumor control. In normal cells, both dose rates induced similar levels of senescence; however, UHDR irradiation led to lower apoptosis induction at clinically relevant doses and early time points post-irradiation.Taken together, these findings further highlight the potential of UHDR irradiation to modulate the response of normal tissues while maintaining comparable tumor control.JuryProf. Thomas BALLIGAND (UNamur), PrésidentProf. Stéphane LUCAS (UNamur), SecrétaireProf. Carine MICHIELS (UNamur)Dr Sébastien PENNINCKX (Hôpital Universitaire de Bruxelles)Prof. Cristian FERNANDEZ (Université de Bern)Dr Rudi LABARBE (IBA)

Our guest lecturer will be Xavier Coumoul, Professor of Toxicology and Biochemistry at Université Paris Cité.Programme09:00 - 09:30 Welcome coffee09:30 - 10:30  LECTURE | Science on the Edge: The Perils and Ethics of Research Integrity10:45 - 12:15   WORKSHOP | Science Under Scrutiny: The Dos and Don’ts of Ethical ResearchThis workshop explores the fundamental principles of scientific integrity and research ethics, addressing key challenges and best practices to ensure ethical research conduct. The Key Topics that may be covered:Defining Ethics & Integrity – Understanding their role in scientific research. Equality vs. Equity – Addressing fairness in academia. The "Publish or Perish" Culture – How pressure influences research misconduct. The Business of Scientific Publishing – Predatory journals and conferences. Scientific Fraud: The Big Three (FFP) – Fabrication, Falsification, Plagiarism and their impact. Detecting Misconduct – Case studies on data manipulation and image forensics (e.g., Elisabeth Bik, PubPeer). Consequences of Fraud – How misconduct affects careers, credibility, and public trust. Fostering Ethical Research – Tools and best practices to uphold integrity. With an interactive approach, the session encourages participants to critically analyze scientific integrity and develop strategies to maintain ethical standards in their work.Participation is free, but registration is mandatory. Registration deadline : April 15, 2025.PhD students will receive certificates of attendance to validate doctoral training credits. Register here

This event will be the perfect opportunity not only to discover the latest advances in the field of biological macromolecules research, but also to share knowledge, collaborate, as well as to showcase the outstanding work of PhD students. PhD students are encouraged to submit an abstract for an oral presentation and/or poster. Five talks will be selected on the basis of received abstracts and added to the final programme. Prizes will be awarded for the best oral presentation and the best poster at the end of the event.  More info about abstract submission and registration on the website